Page 89 - Quest Diagnostics News Today

/PRNewswire/ -- The neurological biomarkers market size is expected to grow by USD 6.92 billion from 2022 to 2027. In addition, the momentum of the market will...

Ameriprise Financial Inc. trimmed its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 11.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 826,010 shares of the medical research company’s stock after selling 107,744 shares during the period. Ameriprise Financial Inc. […]

DnB Asset Management AS lessened its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 11.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 82,385 shares of the medical research company’s stock after selling 10,452 shares […]

Stamford-based Americares is partnering with Quest Diagnostics to provide 10 clinics across the U.S. with no-cost diagnostic services for one year as a means of increasing access to care for low-income, uninsured and underinsured patients.

First Financial Bank Trust Division boosted its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 0.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 83,931 shares of the medical research company’s stock after purchasing an additional 444 shares during the […]

First Financial Bank Trust Division increased its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 0.5% in the second quarter, Holdings Channel reports. The institutional investor owned 83,931 shares of the medical research company’s stock after buying an additional 444 shares during the period. Quest Diagnostics makes up 1.2% of First Financial Bank […]

Discover the 8 healthcare organizations that made Time and Statistas list of the 750 "best" companies, based on employee satisfaction surveys, revenue growth,

Reedley leaders have adopted a temporary ban on future biomedical labs in an effort to prevent private companies from operating without oversight.

An increase of COVID-19 instances and related symptoms is anticipated to fuel market growth. During the pandemic, telemedicine as well as remote monitoring use are projected to rise, increasing the demand for at-home diagnostic testing.Wilmington, Delaware, United States, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The COVID-19 diagnostics market was estimated to have acquired US$ 79.8 billion in 2021. It is anticipated to register a -7.9% CAGR from 2022 to 2031 and by

/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Colorectal Cancer Market Size, Share & Trends Analysis...